TP53 and B-cell chronic lymphocytic leukemia: Based on five prognostic variables (age, serum β2-microglobulin, clinical stage, IGHV mutational status, and TP53 status), the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) categorized patients with CLL into four risk groups.